Your SlideShare is downloading. ×
Baybio Panel: The New Norms of HR [7 April 2010]
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Baybio Panel: The New Norms of HR [7 April 2010]

421
views

Published on

TriNet was invited to host a panel on some of these HR challenges during the conference, and we were excited to facilitate a great discussion between CEOs with growing companies and the 20-25 …

TriNet was invited to host a panel on some of these HR challenges during the conference, and we were excited to facilitate a great discussion between CEOs with growing companies and the 20-25 attendees in the session. We talked about the “New Norms” in HR including growing healthcare and benefits costs, attracting top talent, and the implications of mergers and acquisitions.

See a video excerpt from our panel at http://www.youtube.com/watch?v=dIqB9MacLos

Published in: Business

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
421
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Human Resources Strategies: Defining the New Norms
    April 7, 2010
    3:50 – 5:05 PM
  • 2. Panelists
    Bruce Cohen President and CEO, VitaPath Genetics
    Steven R. Deitcher, M.D. President, CEO and Board Member, HanaBiosciences, Inc.
    Elisa Yu Vice President Operations, CPC Scientific
    Jack Midgley Vice President Products, TriNet
  • 3. The “New Normal” ?
    Escalating Costs of Healthcare Benefits
    What will healthcare reform really mean for the industry?
    How shall bio companies respond to escalating costs?
    Increased Mergers & Acquisitions
    What does this mean for employees and management?
    How shall we set expectations and manage outcomes?
    Challenges Around Hiring & Retention
    How shall we attract and retain the right scientific, technical and business talent?
    Increased Outsourcing of “Non-Core” Functions
    What stays – and what goes?
  • 4. Escalating Healthcare Costs
    Employer Responses:
    • Plan Design Changes
    • 5. Wait Periods
    • 6. Increasing Employee Share
    • 7. Adoption of HDHP vs PPO
    • 8. Differential Funding
    • 9. After 2014:
    • 10. Pay the Fine?
    • 11. Encourage Employees to Buy Through Exchanges?
    • 12. Changes in Perceived Value of Employer-Sponsored Plans?
    Average Annual Health Insurance Premiums and Worker Contributions for Family Coverage
    1999 -2009
    $13,375
    132% Employer Cost Increase
    $5,791
    Source: http://ehbs.kff.org/pdf/2009/7936.pdf
  • 13. Increased Mergers and Acquisitions
    • 1,171 total deals; $295B committed
    • 14. 2009 had highest deal volume (193) and 2d highest deal value ($47B) since 2000
    • 15. 18% of biotech targets had disclosed revenues at time of announcement
    • 16. Four companies announced multiple acquisitions :
    • 17. GSK(4)
    • 18. Amgen (2)
    • 19. Lilly (2)
    • 20. Genzyme (2)
    Biotechnology Mergers and Acquisitions 2000 – 2009
    Number of Deals by Year
    2000 - 2009
    Source: Leading Biotechnology Mergers and Acquisitions for the 10-Year Period Ended December 31, 2009 Revealed by DealSearchOnline.com; 31 March 2010
  • 21. Smaller, High-Wage Companies Are Hiring More Slowly
    • Are biotech companies accelerating hiring?
    • 22. What challenges surround scientific, technical and business hiring?
    US Hiring Index
    105
    -2Since January
    TriNet Hiring Index
    93
    -7Since January
  • 23. Panel Discussion
    Escalating Costs of Healthcare Benefits
    • What will healthcare reform really mean for the industry?
    • 24. How shall bio companies respond to escalating costs?
    Increased Mergers & Acquisitions
    • What does this mean for employees and management?
    • 25. How shall we set expectations and manage outcomes?
    Challenges Around Hiring & Retention
    • How shall we attract and retain the right scientific, technical and business talent?
    Increased Outsourcing of “Non-Core” Functions
    • What stays – and what goes?